#LCSM Chat Topic 8/6/2020: Update on #COVID19 and #LungCancer

#LCSM Chat last discussed COVID-19 and lung cancer in its April 2nd Chat. Much has changed in a mere four months. The USA has had about 4.5 million COVID-19 cases and over 150,000 deaths to date. We have a better understanding of some things related to COVID-19, yet we know more is unknown. The public’s patience with lockdowns and preventative measures wears thin. With each passing day, our necessary human social interactions become more distant, which is harmful to all in the lung cancer community. The strain on some hospitals and clinics… Read More

#LCSM Chat Topic 6/4/2020: #ASCO20 Roundup for #LungCancer

Please join #LCSM Chat Thursday, June 4, 2020, at 8 pm Eastern time (5 pm Pacific) to discuss the ASCO 2020 Annual Virtual Meeting presentations related to lung cancer. Usually, the ASCO Annual Meeting is held in Chicago, Illinois at the end of May/beginning of June, and attracts over 40,000 attendees from around the world.  Due to social distancing recommended during the COVID-19 pandemic, ASCO 2020 is being conducted virtually this year.  The scientific program happened May 29-31, and the educational program will happen August 8-10.  The meeting was FREE to ASCO… Read More

#LCSM Chat Topic 5/7/2020: #COVID19 testing and #lungcancer: Where we stand today

The COVID-19 pandemic is scary, and the situation continues to evolve.  Lung cancer patients and families may have little understanding of COVID-19 testing or how it may affect patient care.  And there is plenty of confusion out there! For our next chat, “COVID-19 testing and lung cancer: Where we stand today,” we will discuss these concerns with pulmonary pathologists and molecular pathologists, who are on the cutting edge of COVID-19 test development and use. Please join #LCSM Chat Thursday, May 7, 2020, at 8 pm Eastern time (5 pm Pacific) to discuss… Read More